Expression of adhesion molecules on leukemic b cells from chronic lymphocytic leukemia patients with predominantly splenic manisfestations

Israel Medical Association Journal

Volumn 6, Issue 3, 2004, Pages 147-151

  Bairey, Osnat ^a,b   Zimra, Yael ^a,b   Rabizadeh, Esther ^a,b   Shaklai, Mati ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adhesion molecules; CD11c; CD44; Chronic lymphocytic leukemia; Splenomegaly

Indexed keywords

ALPHA4 INTEGRIN; BETA 2 MICROGLOBULIN; BETA1 INTEGRIN; BETA2 INTEGRIN; BETA3 INTEGRIN; CD19 ANTIGEN; CELL ADHESION MOLECULE; GLYCOPROTEIN P 15095; HERMES ANTIGEN; HOMING RECEPTOR; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; CELL ISOLATION; CELL TRANSPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEUKEMIA CELL; LYMPHOCYTE HOMING; PROTEIN EXPRESSION; PROTEIN FAMILY; SPLENOMEGALY; TISSUE SPECIFICITY;

AGED; AGED, 80 AND OVER; ANTIGENS, CD11; ANTIGENS, CD18; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CELLS, CULTURED; COHORT STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, B-CELL, CHRONIC; MALE; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPLENOMEGALY;

EID: 1642348714     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Monserrat E, Rozman C. Chronic lymphocytic leukemia: prognostic factors and natural history. Baillieres Clin Haematol 1993;6:849-66.
2. Rai K, Sawitsky A, Cronkite E, Chanana AD, Levy RN, Pasternak B. Clinical staging of chronic lymphocytic leukemia. Bloofd 1975;46:219-34.
3. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from multivariate survival analysis. Cancer 1981;48:198-206.
4. Skinnider LF, Tan L, Schmit J, Armitage G. Chronic lymphocytic leukemia. A review of 745 cases and assessment of clinical staging. Cancer 1982;50:2951-5.
5. Prokocimer M, Modan M, Lusky A, Hershko C. Multivariate analysis of prognostic factors in chronic lymphocytic leukemia. Isr J Med Sci 1985;21:490-8.
6. Kipps TJ. Chronic lymphocytic leukemia and related diseases. In: Beutler E, Coller B, Lichtman M, Kipps TJ, Seligsohn U, eds. New York: Williams Hematology. International edition: McGraw-Hill, 2001:1163-94.
7. Binett JL, Leporrier M, Dighiero G, et al. A clinical staging system for chronic lymphocytic leukemia. Cancer 1977;40:835-64.
8. Dighiero G, Charron D, Debre P, et al. Identification of a pure splenic form of chronic lymphocytic leukemia. Br J Haematol 1979;41:169-76.
9. Baccarani M, Cavo M, Gobbi M, Lauria F, Tua S. Staging of chronic lymphocytic leukemia. Blood 1982;59:1191-6.
10. Singh AK. A prospective study of the evolution of chronic lymphocytic leukemia. Leuk Lymphoma 1992;7:87-97.
11. Drillenburg P, Pals St. Cell adhesion receptors in lymphoma dissemination. Blood 2000;95:1900-10.
12. Pals ST, Drillenburg P, Radaszkiewicz T, Manten-Horst E. Adhesion molecules in the dissemination of non-Hodgkin's lymphomas. Acta Haematol 1997;97:73-80.
13. Angelopoulou MK, Kontopidou FN, Pangalis GA. Adhesion molecules in B-chronic lymphoproliferative disorders. Semin Hematol 1999;36:178-97.
14. De rossi G, Zarcone D, Mauro F, et al. Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: Malignant cell phenotypes define distinct disease subsets. Blood 1993;81:2679-87.
15. Kimby E, Rincon J, Patarroyo M, Mellstedt H. Expression of adhesion molecules CD11/CD18 (Leu-CAMs, beta 2-integrins). CD54 (ICAM-I) and CD58 (LFA-3) in B-chronic lymphocytic leukemia. Leuk Lymphoma 1994;13:297-306.
16. Beht SI, Korinth D. Schriever F. Differential adhesion pattern of B cell chronic lymphocytic leukemia cells. Leukemia 1998;12:71-7.
17. Csanaky G, Matutes E, Vass JA, Morilla R, Catovsky D. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia 1997;11:408-15.
18. Domingo A, Gonzalez-Barca E, Casteiisague X, et al. Expression of adhesion molecules in 113 patients with B-cell chronic lymphocytic leukemia: Relationship with clinicoprognostic features. Leuk Res 1997;21:67-73.
19. Freedman AS, Nadler LM. Immunologic markers in B-cell chronic lymphocytic leukemia. In: Cheson BD, ed. Chronic Lymphocytic Leukemia, Scientific Advances and Clinical Developments. New York: Marcel Dekker, 1993.
20. Bairey O, Stark P, Blickstein D, Prokocimer M, Luboshitz J, Shaklai M. Stage II (S) chronic lymphocytic leukemia - an entity with a favorable clinical course [Abstract]. Blood 1997;901(Suppl 251b).
21. Sarfati M, Chevret S, Chastang C, et al. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 1996;88:4259-64.
22. 2-microglobulin in B-cell chronic lymphocytic leukemia. Eur J Haematol 1999;62:117-22.
23. Binet JL, Vaugier G, Dighiero G, d'Athis P. Charron D. Investigation of a new parameter in chronic lymphocytic leukemia: The percentage of large peripheral lymphocytes determined by Hemalog D. Prognostic significance. Am J Med 1977;63:683-5.
24. Molica S, Dattilo A, Mannella A. Cd11c epression in B-cell chronic lymphocytic leukemia. Blood 1993;81:2466.
25. De Rossi G, Tenca C, Cerruti G, et al. Adhesion molecule expression on B-cells from acute and chronic lymphoid leukemias. Leuk Lymphoma 1994;16:31-6.